TSRI's main web site PROMISE mirror at TSRI Metalloprotein DB site Created: 13 January 1998
Last modified: 22 February 1999


Nitric oxide synthases

Prosthetic group Oxidation states
FAD
FAD image

Flavin adenine dinucleotide (FAD)
FAD;

FAD· (semiquinone);

FADH2

FMN
FMN image

Flavin mononucleotide (FMN)
FMN;

FMN· (semiquinone);

FMNH2

BH4
BH4 image

(6R)­5,6,7,8­Tetrahydrobiopterin (BH4)
BH4 (active form);

BH2 (inactive form)

Zn
Zn(Cys)4 image
Zn(SgammaCys)4
[Zn(Cys)4]2-
Haem Haem type Haem iron coordination Axial iron ligand(s) Formal iron
oxidation/spin
states
Haem b image
Haem b
Haem-Cys image
Pentacoordinate
SgammaCys
FeII (S=2);
FeIII (S=5/2)
Cys-haem-NO image
Hexacoordinate
SgammaCys;

NO, CO or other ligand

FeII (S=0);
FeIII (S=1/2)
Cys-haem=O image
Hexacoordinate
SgammaCys;

O (O·)

FeIV (S=1)

Nitrogen monoxide (·NO), commonly referred to as nitric oxide in the biochemical literature [1], is a free radical generated in biological systems. ·NO functions at low concentrations as a signal in many diverse physiological processes such as blood pressure control, neurotransmission, learning and memory, and at high concentrations as a defensive cytotoxin (see list of reviews on structure and function of nitric oxide synthases). Nitric oxide synthase (NOS; EC 1.14.13.39) enzymes produce ·NO by catalysing a five­electron oxidation of a guanidino nitrogen of L­arginine (L­Arg). Oxidation of L­Arg to L­citrulline occurs via two successive monooxygenation reactions producing Nomega­hydroxy­L­arginine as an intermediate (1). 2 mol of O2 and 1.5 mol of NADPH are consumed per mole of ·NO formed [2 and references therein].

NOSs are the only enzymes known to simultaneously require five bound cofactors/prosthetic groups: FAD, FMN, haem, tetrahydrobiopterin (BH4) and Ca2+-calmodulin (CaM). In mammals, three distinct genes encode NOS isozymes: neuronal (nNOS or NOS­1), cytokine­inducible (iNOS or NOS­2) and endothelial (eNOS or NOS­3) [3]. Some properties of mammalian NOS isozymes are summarised in the table:

Enzyme Gene No. of exons No. of residues Subcellular location Regulation
nNOS NOS1 29 1429-1433 Mainly soluble (brain); mainly particulate (skeletal muscle) Ca2+/CaM
iNOS NOS2 27 1144-1153 Mainly soluble Cytokine­inducible; Ca2+­independent
eNOS NOS3 26 1203-1205 Mainly particulate Ca2+/CaM

iNOS and nNOS are soluble and found predominantly in the cytosol, while eNOS is membrane associated. eNOS localisation to endothelial membranes is mediated by cotranslational N­terminal myristoylation and post­translational palmitoylation. The enzymes exist as homodimers, each monomer consisting of two major domains: N­terminal oxygenase domain, which belongs to the class of haem-thiolate proteins, and C­terminal reductase domain, which is homologous to NADPH:P450 reductase. The interdomain linker between the oxygenase and reductase domains contains a CaM­binding sequence. nNOS contains an additional N­terminal domain (`DHR domain') which shows homology to syntrophins, a family of dystrophin­binding proteins, some protein tyrosine phosphatases, protein kinases and some other proteins [4]. The subcellular localisation of nNOS in skeletal muscle is mediated by anchoring of nNOS to dystrophin. A schematic alignment of cofactor binding sites of the three NOS isozymes follows:

nNOS
DHR
haem
CaM
FMN
FAD
NADPH
iNOS
haem
CaM
FMN
FAD
NADPH
eNOS Myr
haem
CaM
FMN
FAD
NADPH

All NOS isozymes are catalytically self­sufficient. The electron flow in the ·NO synthase reaction is

CaM binding to nNOS has been shown to regulate catalytic activity by triggering electron flux from FMN to haem, thereby coupling the oxygenase and reductase domains. CaM also facilitates NADPH­dependent reduction of cytochrome c and ferricyanide in BH4­ and haem­depleted nNOS (1.2). The continual activity of iNOS is explained by its exceptionally high avidity for CaM. The role of reduced pterin cofactor remains unclear (cf. views that BH4 is required in catalytic [5] or stoichiometric [6] quantities). It was hypothesised that redox cycling BH4<->BH2 takes place in situ while bound to NOS [2]. A number of enzyme properties which are thought to involve pterin were investigated using pterin­free iNOS and different tetrahydro­ or dihydropterins. It was found that ·NO synthesis and the ability to increase haem­dependent NADPH oxidation in response to substrates require fully reduced tetrahydropterins and are independent of side chain structure; in contrast, pterin binding affinity and its ability to shift the haem iron to high­spin state, stabilise the ferrous haem iron coordination structure, support haem iron reduction, and promote dimerisation of iNOS subunits were independent of pterin oxidation state but dependent on pterin side chain structure or stereochemistry [7].

The 3­D structures have been reported for iNOS oxygenase domain (iNOSox) complexes with the NOS inhibitors imidazole and aminoguanidine [8], iNOSox dimer complex with BH4 and L­Arg [9], and BH4­bound and BH4­free dimers of constitutive eNOS oxygenase domain (eNOSox) [10]. NOSox has a novel nonmodularalpha/ß fold, resembling "a baseball catcher's mitt for a left hand" [8]. The fold consists of a winged ß­sheet with projecting ß­hairpins and flanking alpha­helices. Haem is situated in the ß­sheet `palm' with its distal face directed toward a large cavity. In iNOSox-imidazole complex, the low­spin haem iron is axially coordinated to proximal Cys­194 and to exogenous imidazole. The L­Arg analogue aminoguanidine binds in the distal pocket adjacent to the haem is such a way that one guanidino nitrogen is directed toward the activated oxygen binding site.

The crystal structure of eNOSox dimer reveals a zinc ion tetrahedrally coordinated to pairs of symmetry­related Cys residues at the dimer interface [10].

NOS in enzyme databases

ENZYME LIGAND BRENDA Official name Alternative names
1.14.13.39 1.14.13.39 1.14.13.39 Nitric oxide synthase NO synthase; NO synthetase; NOS

NOS in motif databases

PRINTS ID PRINTS AC PROSITE/BLOCKS ID PROSITE AC BLOCKS AC
FPNCR PR00371
-
-
-
FLAVODOXIN PR00369 FLAVODOXIN PS00201 BL00201

NOS in alignment databases

Protein Superfamily Protein Homology Domain Pfam LPFC 3­D alignment
03633; nitric oxide synthase 00062; flavodoxin PF00175; oxidored_fad
PF00258; flavodoxin
-

NOSs in 3­D databases

NOS oxygenase domain contains a single haem b group.

PDB scop BSMRELI
Base
HeaderMMS Abstract ¹
1noc
-
1noc
-
Inducible nitric oxide synthase oxygenase domain (Delta114) (complex with type I E. coli chloramphenicol acetyl transferase and imidazole); mouse macrophage (recombinant form expressed in Escherichia coli)
-
1nos
-
1nos
-
Inducible nitric oxide synthase oxygenase domain (Delta114) (complex with imidazole); mouse macrophage (recombinant form expressed in Escherichia coli)
-
2nos
-
2nos
-
Inducible nitric oxide synthase oxygenase domain (Delta114) (complex with aminoguanidine and imidazole); mouse macrophage (recombinant form expressed in Escherichia coli)
-

¹ Macromolecular Structures abstract. Full text is available to BioMedNet Members

References

  1. Koppenol, W.H. and Traynham, J.G. (1996) Say NO to nitric oxide: Nomenclature for nitrogen­ and oxygen­containing compounds. Methods Enzymol. 268, 3-7.
  2. Liu, Q. and Gross, S.S. (1996) Binding sites of nitric oxide synthases. Methods Enzymol. 268, 311-324.
  3. Knowles, R.G. and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258.
  4. Ponting, C.P. and Phillips, C. (1995) DHR domains in syntrophins, neuronal NO synthases and other intracellular proteins. Trends Biochem. Sci. 20, 102-103.
  5. Giovanelli, J., Campos, K.L. and Kaufman, S. (1991) Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc. Natl. Acad. Sci. USA 88, 7091-7095.
  6. Hevel, J.M. and Marletta, M.A. (1992) Macrophage nitric oxide synthase: relationship between enzyme­bound tetrahydrobiopterin and synthase activity. Biochemistry 31, 7160-7165.
  7. Presta, A., Siddhanta, U., Wu, C., Sennequier, N., Huang, L., Abu­Soud, H.M., Erzurum, S. and Stuehr, D.J. (1998) Comparative functioning of dihydro­ and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry 37, 298-310.
  8. Crane, B.R., Arvai, A.S., Gachhui, R., Wu, C., Ghosh, D.K., Getzoff, E.D., Stuehr, D.J. and Tainer, J.A. (1997) The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278, 425-431.
  9. Crane, B.R., Arvai, A.S., Ghosh, D.K., Wu, C., Getzoff, E.D., Stuehr, D.J. and Tainer, J.A. (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279, 2121-2126.
  10. Raman, C.S., Li, H., Martásek, P., Král, V., Masters, B.S.S. and Poulos, T.L. (1998) Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95, 939-950.
Bibliography on structural studies of nitric oxide synthases
Reviews on nitric oxide synthases
The Nitric Oxide Home Page
Directory of P450­containing Systems